The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study

A Charidimou, G Boulouis, MP Frosch… - The Lancet …, 2022 - thelancet.com
Background Cerebral amyloid angiopathy (CAA) is an age-related small vessel disease,
characterised pathologically by progressive deposition of amyloid β in the cerebrovascular …
被引用次数：277 相关文章
[HTML] nih.gov

[HTML][HTML] The Boston Criteria v2. 0 for cerebral amyloid angiopathy: A multicentre MRI-neuropathology diagnostic accuracy study

A Charidimou, G Boulouis, MP Frosch… - The Lancet …, 2022 - ncbi.nlm.nih.gov
Background: The Boston Criteria are used worldwide for in vivo diagnosis of cerebral
amyloid angiopathy (CAA) but have not been updated since 2010, prior to emergence of …

The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study

A Charidimou, G Boulouis, MP Frosch, JC Baron… - The Lancet …, 2022 - Elsevier
Background Cerebral amyloid angiopathy (CAA) is an age-related small vessel disease,
characterised pathologically by progressive deposition of amyloid β in the cerebrovascular …

[引用][C] The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study

A Charidimou, G Boulouis, MP Frosch, JC Baron… - The Lancet …, 2022 - cir.nii.ac.jp
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective,
MRI–neuropathology diagnostic accuracy study | CiNii Research CiNii 国立情報学研究所 学術 …

The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.

A Charidimou, G Boulouis, MP Frosch… - The Lancet …, 2022 - europepmc.org
Background Cerebral amyloid angiopathy (CAA) is an age-related small vessel disease,
characterised pathologically by progressive deposition of amyloid β in the cerebrovascular …
[HTML] ed.ac.uk

[HTML][HTML] The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study

A Charidimou, G Boulouis, MP Frosch… - The Lancet …, 2022 - research.ed.ac.uk
BACKGROUND: Cerebral amyloid angiopathy (CAA) is an age-related small vessel
disease, characterised pathologically by progressive deposition of amyloid β in the …

The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study

A Charidimou, G Boulouis, MP Frosch… - The Lancet …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Cerebral amyloid angiopathy (CAA) is an age-related small vessel disease,
characterised pathologically by progressive deposition of amyloid β in the cerebrovascular …

The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study

A Charidimou, G Boulouis, MP Frosch… - Lancet …, 2022 - epub.ub.uni-muenchen.de
Background Cerebral amyloid angiopathy (CAA) is an age-related small vessel disease,
characterised pathologically by progressive deposition of amyloid beta in the …

The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study

A Charidimou, G Boulouis, MP Frosch… - The Lancet …, 2022 - discovery.ucl.ac.uk
BACKGROUND: Cerebral amyloid angiopathy (CAA) is an age-related small vessel
disease, characterised pathologically by progressive deposition of amyloid β in the …

[引用][C] The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.

A Charidimou, G Boulouis, MP Frosch, JC Baron… - 2022 - lilloa.univ-lille.fr
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective,
MRI-neuropathology diagnostic accuracy study. Toggle navigation English français Aide | Contact …